Business · 31/01/2011Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Pre-Storage Leukocyte Reduction of Blood Components
Summary
The Food and Drug Administration (FDA) has released a draft document outlining recommendations for blood establishments to reduce leukocytes in whole blood and blood components before storage, replacing a previous draft guidance from 2001 and superseding a 1996 memorandum.
Original source language: Federal Register — Health and Human ServicesOpen original release →